Randomised, double-blind, placebo-controlled study to assess long-term effect of dupilumab on prevention of lung function decline (LFD) in patients with uncontrolled moderate-to-severe asthma: ATLAS trial

Autor: L De Prado Gomez, I Pavord, W Busse, C E Brightling, M E Wechsler, K F Rabe, M Zhang, J Xing, J A Jacob-Nara, P J Rowe
Rok vydání: 2022
Zdroj: 05.02 - Monitoring airway disease.
DOI: 10.1183/13993003.congress-2022.2288
Databáze: OpenAIRE